Humana's 2025 Medicare Advantage Plans Focus on Quality, Affordable Healthcare Tailored to the Needs of Consumers
(NYSE: HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025. This press release features multimedia. View the full release here: Humana's Medicare Advantage plans are tailored to meet the varying needs of Medicare beneficiaries,
Global health company The Cigna Group (NYSE:CI) will release its third quarter 2024 financial results on Thursday, October 31 ...
Pharmacy benefit managers run by health insurers have once again come under scrutiny in the U.S. Congress. Two leading Senate ...
When Cigna considered a tie-up with Humana last year, Humana was worth about $60 billion. That made it a sizable target for Cigna, whose market value was then about $80 billion. Cigna eventually walke ...
As the Medicare market continues to rapidly evolve, Cigna Healthcare℠ offers customers stable plans, a consistent service ...
A pair of U.S. lawmakers is urging the FTC to investigate the parent companies of two large PBMs over concerns that patients ...
Cigna stock could be set up to generate strong total returns in the next couple of years. Read more about recent earnings ...
Slowly but surely, Americans are regaining their vigor. The third annual Vitality in America report from The Cigna Group ...
In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Cigna (CI – Research Report), with a price target ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
One of the largest health systems in the Houston area was still in negotiations to keep its hospitals in network with Cigna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback